Xolair or OIT? The better option is...
What topic would you like discussed? Text us! The headlines makes it sound simple: omalizumab (Xolair) performs as well as or better than multi-food oral immunotherapy for food allergy. But once you look under the hood, the story gets a lot more nuanced and a lot more real. Fresh from the AAAAI 2026 conference, I walk you through what the new data actually show, why the study design isn't ideal, and what parents should ask their allergist before choosing a path, whether that be with Xolair, OIT, SLIT, or avoidance. Link to the articles I mention: Food Allergy Peds Hub: https://foodallergypedshub.hoytallergy.com/newsletters/the-food-allergy-friday-newsletter/posts/is-xolair-superior-to-oit Doximity: https://opmed.doximity.com/articles/aaaai-2026-good-science-great-connections If this helps you think more clearly about your child's food allergy treatment, subscribe, share the episode with a friend, and leave a review so more families can find it. Resources 📖 Navigating Food Allergies: A Parent’s Guide to Care, Coverage, and Confidence by Dr. Alice Hoyt - order from Amazon and more For Parents ➡️ Office Hours for Parents For Providers ➡️ Food Allergy Pediatric Hub For Schools ➡️ Code Ana For Potential Patients ➡️ Hoyt Institute of Food Allergy 🔎 Find an Allergist AAAAI Allergist Finder ACAAI Allergist Finder OIT Allergist Finder This podcast is the official podcast of the Hoyt Institute of Food Allergy . Information on, within, and associated with this site and Food Allergy and Your Kiddo is for educational purposes only and is not medical advice.